Abcellera's first program with regeneron in multi-target collaboration advances in preclinical development

Vancouver, british columbia--(business wire)---- $abcl--abcellera's first program with regeneron in multi-target collaboration advances into late-stage preclinical development

ABCL Ratings Summary

ABCL Quant Ranking